Tag: PARPi

The SOLO1 trial: Olaparib significantly delays progression of advanced ovarian cancer

Maintenance Olaparib Rechallenge in Platinum-Sensitive Relapsed Ovarian Cancer

byDaniel Goldshteinand1 others

October 16, 2023

1. Median PFS was improved in the olaparib arm vs placebo, with an HR 0.57 in the BRCAm cohort and ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Worsening kidney function observed following SARS-CoV-2 infection in children
2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [May 23rd, 2025]
Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF

No Result

View All Result